Stock Events

Stock Events

Embecta 

€4.85
82
+€0.03+0.64% 06:03 Today

Statistics

Day High
4.85
Day Low
4.85
52W High
12.9
52W Low
2.52
Volume
0
Avg. Volume
0
Mkt Cap
274.91M
P/E Ratio
-
Dividend Yield
5.71%
Dividend
0.28

Upcoming

Dividends

5.71%Dividend Yield
Sep 26
€0.01
Jun 26
€0.01
Mar 26
€0.13
Dec 25
€0.13
Sep 25
€0.13
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-11.5%
1Y Growth
-28.09%

Earnings

1DecExpected
Q4 2025
Q1 2026
Q2 2026
Next
0.23
0.35
0.48
0.6
Expected EPS
0.24945799999999999
Actual EPS
N/A

Financials

8.55%Profit Margin
Profitable
2022
2023
2024
2025
968.05MRevenue
82.81MNet Income

Analyst Ratings

3.04Average Price Target
The highest estimate is 3.79.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
67%
Sell
33%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JX7.MU. It's not an investment recommendation.
Realty Income
18
O
Apple
16
AAPL
AT&T
16
T
Coca-Cola
15
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a major player in the medical devices sector, directly competing with Embecta in the diabetes management space, including insulin pumps and glucose monitoring systems.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products, competing with Embecta in areas such as glucose monitoring.
Dexcom
DXCM
Mkt Cap34.27B
DexCom specializes in continuous glucose monitoring (CGM) systems, a direct competitor to Embecta's diabetes care products.
Tandem Diabetes Care
TNDM
Mkt Cap1.49B
Tandem Diabetes Care is a direct competitor in the insulin pump market, offering advanced diabetes management systems.
Insulet
PODD
Mkt Cap10.07B
Insulet Corporation specializes in tubeless insulin pump technology, competing in the insulin delivery market alongside Embecta.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk is a global healthcare company with a strong focus on diabetes care, including insulin and devices, competing with Embecta's offerings.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is involved in diabetes care through its insulin and glucose monitoring products, making it a competitor to Embecta.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb, through its acquisition of MyoKardia, has expanded into various healthcare sectors, potentially competing with Embecta in the broader medical devices and healthcare market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, competes in the healthcare market, including areas that overlap with Embecta's diabetes care products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation operates in the medical devices sector, competing in various areas that could intersect with Embecta's market, including diabetes care solutions.

About

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Show more...
CEO
Devdatt Kurdikar
Employees
1850
Country
United States
ISIN
US29082K1051
WKN
000A3DGNE

Listings

STU
DE
JX7.STU
MU
DE
JX7.MU
MX
MX
EMBC.MX
XNAS
US
EMBC

0 Comments

Share your thoughts

FAQ

What is Embecta stock price today?▼
The current price of JX7.MU is €4.85 EUR — it has increased by +0.64% in the past 24 hours. Watch Embecta stock price performance more closely on the chart.
What is Embecta stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Embecta stocks are traded under the ticker JX7.MU.
Is Embecta stock price growing?▼
JX7.MU stock has risen by +12.37% compared to the previous week, the month change is a +50.17% rise, over the last year Embecta has showed a -60.87% decrease.
What is Embecta market cap?▼
Today Embecta has the market capitalization of 274.91M
When is the next Embecta earnings date?▼
Embecta is going to release the next earnings report on December 01, 2026.
What were Embecta earnings last quarter?▼
JX7.MU earnings for the last quarter are 0.48 EUR per share, whereas the estimation was 0.23 EUR resulting in a +110.66% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Embecta revenue for the last year?▼
Embecta revenue for the last year amounts to 968.05M EUR.
What is Embecta net income for the last year?▼
JX7.MU net income for the last year is 82.81M EUR.
Does Embecta pay dividends?▼
Yes, JX7.MU dividends are paid quarterly. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (FWD)% is 5.71%.
How many employees does Embecta have?▼
As of September 04, 2026, the company has 1,850 employees.
In which sector is Embecta located?▼
Embecta operates in the Health & Wellness sector.
When did Embecta complete a stock split?▼
Embecta has not had any recent stock splits.
Where is Embecta headquartered?▼
Embecta is headquartered in PARSIPPANY, United States.